Skip to content

AOCI at other companies

Eli Lilly logo
Eli LillyLLY
-$2.83B+24.9%
Merck & Co. logo
Merck & Co.MRK
-$4.06B+18.2%
Amgen logo
AmgenAMGN
-$190M+17.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$11.9M-59.1%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$802K-13.1%
AbbVie logo
AbbVieABBV
-$1.15B+33.8%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's AOCI?
KLRS (KLRS) reported AOCI of -$49K in Q1 2026.
What is the long-term trend for KLRS's AOCI?
Over 4 years (2021 to 2025), KLRS's AOCI has grown at a -55.6% compound annual growth rate (CAGR), from -$155K to $6K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.